Does diclofenac (Nonsteroidal Anti-Inflammatory Drug (NSAID)) cause problems in people with heart trouble like ibuprofen (NSAID) does?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diclofenac Causes Significant Cardiovascular Problems in People with Heart Trouble Similar to Ibuprofen

Diclofenac should be avoided in patients with heart trouble as it poses a higher cardiovascular risk than ibuprofen, with studies showing a relative risk of 1.63 for vascular events compared to 1.51 for ibuprofen. 1

Cardiovascular Risks of NSAIDs in Heart Disease

Comparative Risk Profile

  • Diclofenac has one of the highest cardiovascular risks among NSAIDs:

    • Relative risk for vascular events: 1.63 (95% CI: 1.12-2.37) 1
    • Mortality risk in post-MI patients: 2.40 (95% CI: 2.09-2.80) 1
    • Risk of recurrent MI: 1.54 (95% CI: 1.23-1.93) 1
  • Ibuprofen also increases cardiovascular risk but slightly less than diclofenac:

    • Relative risk for vascular events: 1.51 (95% CI: 0.96-2.37) 1
    • Mortality risk in post-MI patients: 1.50 (95% CI: 1.36-1.67) 1
    • Risk of recurrent MI: 1.25 (95% CI: 1.07-1.46) 1

Mechanism of Cardiovascular Harm

Both diclofenac and ibuprofen increase cardiovascular risk through COX-2 inhibition, which creates an imbalance between prothrombotic thromboxane A2 and antithrombotic prostacyclin, resulting in higher risk of thrombotic events 2. Diclofenac's higher COX-2 selectivity explains its greater cardiovascular risk.

Recommendations for Patients with Heart Disease

Alternative Pain Management Options

The American Heart Association and American College of Cardiology recommend a stepped-care approach for pain management in patients with heart disease 1:

  1. First-line options (preferred):

    • Acetaminophen (up to 3g/day in renal impairment) 2
    • Small doses of narcotics
    • Non-acetylated salicylates
  2. Second-line option (if first-line fails):

    • Naproxen (has the lowest cardiovascular risk among NSAIDs with RR 0.92) 1, 3
  3. Last resort (only if all other options fail):

    • NSAIDs with lower COX-2 selectivity at lowest effective dose for shortest time

Special Considerations

  • Diclofenac can worsen heart failure through fluid retention and edema 4
  • In patients taking aspirin for cardioprotection, diclofenac doesn't interfere with aspirin's antiplatelet effect (unlike ibuprofen) 1
  • Diclofenac can increase blood pressure and reduce effectiveness of antihypertensive medications 4

Monitoring Requirements

If diclofenac must be used in a patient with heart disease (which should be avoided if possible):

  • Monitor blood pressure within 1-2 weeks of starting therapy 4
  • Watch for signs of worsening heart failure (fluid retention, edema) 4
  • Use lowest effective dose for shortest possible duration 1
  • Discontinue immediately if cardiovascular symptoms worsen 4

Conclusion

For patients with heart trouble, diclofenac poses significant cardiovascular risks similar to or greater than ibuprofen. The evidence strongly supports avoiding both medications in patients with established cardiovascular disease, with diclofenac carrying a particularly high risk of mortality and recurrent cardiac events.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pain Management in Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.